51.5% 1 More likely to be commercially insured Prescriber trends Primary care (family) physicians were the most predominant prescribers in 2022, followed by endocrinologists Specialists prescribed semaglutide therapy for commercial enrollees more frequently than for managed Medicaid, indicating barriers to specialty care for lower-income patients Provider Specialties by Label Status Cohorts Observations on Specialist Trends Interventional cardiology emerged as a significant prescribing specialty for semaglutide therapy in both 2022 and 2023
Journal of Photochemistry and Photobiology B: Biology , 170 , 197207
Patients on multiple diabetes medications should closely monitor their blood sugar levels
Regulatory status Not FDA-approved
In treatment of acute exacerbations of multiple sclerosis daily doses of 200 mg of prednisolone for a week followed by 80 mg every other day or 48 mg dexamethasone every other day for 1 month have been shown to be effective
Clin Ther 38:26422651 Armstrong MJ, Houlihan DD, Rowe IA et al (2013) Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program